Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01MAC
|
|||
| Former ID |
DNC008966
|
|||
| Drug Name |
Isosorbide-2-(butylcarbamate)-5-mononitrate
|
|||
| Synonyms |
Isosorbide-2-(butylcarbamate)-5-mononitrate; CHEMBL494520; BDBM50253227
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H18N2O7
|
|||
| Canonical SMILES |
CCCCNC(=O)OC1COC2C1OCC2O[N+](=O)[O-]
|
|||
| InChI |
1S/C11H18N2O7/c1-2-3-4-12-11(14)19-7-5-17-10-8(20-13(15)16)6-18-9(7)10/h7-10H,2-6H2,1H3,(H,12,14)/t7-,8+,9+,10+/m0/s1
|
|||
| InChIKey |
ZRPGNSMQMBUVBC-SGIHWFKDSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. J Med Chem. 2008 Oct 23;51(20):6400-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.